| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Canada | 3 | |
| #3 | Australia | 2 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Measurement | |
| #5 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Unspecified technologies | |
| #3 | Microorganisms | |
| #4 | Microbiology | |
| #5 | Peptides | |
| #6 | Animal care | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vandenburgh Herman H | 4 |
| #2 | Latif Syed Abdul | 3 |
| #3 | Morris David J | 3 |
| #4 | Newton Julie L | 2 |
| #5 | Ge Renshan | 2 |
| #6 | Marotta Charles A | 2 |
| #7 | Hardy Matthew P | 2 |
| #8 | Majocha Ronald | 2 |
| #9 | Majocha Ronald E | 2 |
| #10 | Tate Barbara A | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2524165A1 | Selective testicular 11.beta.-hsd inhibitors and methods of use thereof | |
| US6172277B1 | Non-transgenic rodent model of alzheimer's disease | |
| US6010721A | Glycyrrhetinic-acid-like factor | |
| US5869041A | Delivery of bioactive compounds to an organism | |
| AU7043894A | Composition and method for (in vivo) imaging of amyloid deposits |